NEW YORK — In certain cases, short-term tamponade with perfluoro-n-octane provides good anatomical and functional outcomes, according to a poster presented at the American Society of Retina Specialists annual meeting.
In a study, Katarzyna Chwiejczak, MD, FEBO, and co-authors retrospectively analyzed a series of 42 eyes of 42 patients who underwent vitrectomy with short-term perfluoro-n-octane (PFO) endotamponade at the Sydney and Sydney Eye Hospital between September 2019 and June 2021.
The participants presented with a variety of conditions, including giant retinal tears, retinal